Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-1995 | 07-1994 | |
| Assets | ||
| Current Assets | ||
| Marketable Securities | 40 | 7 |
| Receivables | 220 | 60 |
| Inventories | 20 | 6 |
| Other current assets | 10 | -2 |
| TOTAL | $290 | $70 |
| Non-Current Assets | ||
| Other Non-Current Assets | 2 | 3 |
| TOTAL | $2 | $3 |
| Total Assets | $420 | $210 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 160 | 40 |
| Accrued Expenses | 5 | 5 |
| TOTAL | $160 | $60 |
| Non-Current Liabilities | ||
| Long Term Debt | 20 | 30 |
| TOTAL | $20 | $30 |
| Total Liabilities | $180 | $90 |
| Shareholders' Equity | ||
| Common Shares | 590 | 480 |
| Retained earnings | -360 | -360 |
| Other shareholders' equity | 0 | -10 |
| TOTAL | $230 | $110 |
| Total Liabilities And Equity | $410 | $200 |